India-based firm Lupin has joined the pegfilgrastim parade with the FDA’s approval of Armlupeg (pegfilgrastim-unne), the seventh biosimilar for Amgen’s Neulasta approved in the US since 2018. Like ...
Armlupeg, a biosimilar to Neulasta, is approved for reducing febrile neutropenia in non-myeloid malignancy patients undergoing myelosuppressive chemotherapy. Lupin's FDA-approved facility in India ...
Data demonstrate a high degree of similarity between Armlupeg and the reference product. The Food and Drug Administration (FDA) has approved Armlupeg ™ (pegfilgrastim-unne), a biosimilar to Neulasta ® ...
The drug decreases the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. Nilesh Gupta, MD, Lupin, ...
There are few things as life-affirming as baking a chocolate cake from scratch, but sometimes it’s simply not possible. Maybe your kid is sick, or you’re running late, or you forgot to pick up ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Antara Sinha Antara Sinha is a writer covering food and kitchen gear. She has ...
The Mix G2 features Intel’s latest Core Ultra 9 275HX processor, which includes 24 cores and 24 threads with a maximum boost clock of 5.4GHz. It supports a 120W TDP and includes a built-in NPU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results